Snowball logo
logo
RVU

Ryvu Therapeutics SA

RVU WAR
17.08-0.42  (2.4%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
11.1938.846.8677.9762.2562.27
COGS
13.7317.4117.5519.58179.392
Gross Profit
(2.538736)21.429.3158.39(117)(29.73)
Operating Expenses & Income
Operating Income
(103.8)(78.42)(100.9)(122.1)(122.2)(94.29)
Total Operating Expenses
75.9893.07130.3180.55.11964.56
R&D Expenses
15.0225.99----
Selling General & Admin Expenses
4.3297855.557----
Earnings from Continuing Operations
Interest Expense
(0.442)(1.089)(0.097)(3.808)(8.803)(9.389)
Interest Income
0.06141.14513.839.1285.0924.011
Income Tax Expense
0.1159464.587-0.2970.0880.254
Net Income
Net Income
(79.08)(83.78)(92.11)(111.4)(101.2)(88.6)
Supplemental
EBIT
(78.52)(78.11)(92.02)(107.3)(122.2)(95.1)
EBITDA
(65.96)(65.21)(81.04)(96.83)(112.7)(85.94)
In millions of PLN, except % and values per 1 share